Discovery of GBA-16-24 as a highly potent, selective ATR inhibitor for the treatment of FLT3-mutated acute myeloid leukemia.
发现 GBA-16-24 是一种高效、选择性的 ATR 抑制剂,可用于治疗 FLT3 突变的急性髓系白血病。
期刊:RSC Medicinal Chemistry
影响因子:3.6
doi:10.1039/d5md01005e
Li Ping, Ren Haiyan, Lan Xinyan, Li Junfei, Liu Zhi, Liu Huashuo, Zheng Zhijie, Zeng Tianyan, Wang Peili, Sun Mingyang, Xu Lei, Zhang Yanyan, Zhou Yubo, Li Jia, Wang Mingliang, Jiang Kailong